| mRNA |
BRD-A71883111 |
CTRPv2 |
pan-cancer |
AAC |
0.0056 |
0.9 |
| mRNA |
sirolimus:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.0047 |
0.9 |
| mRNA |
OSI-027 |
CTRPv2 |
pan-cancer |
AAC |
0.0048 |
0.9 |
| mRNA |
BRD-K34222889 |
CTRPv2 |
pan-cancer |
AAC |
-0.0042 |
0.9 |
| mRNA |
SCH-529074 |
CTRPv2 |
pan-cancer |
AAC |
-0.0051 |
0.9 |
| mRNA |
CAL-101 |
GDSC1000 |
pan-cancer |
AAC |
-0.0039 |
0.9 |
| mRNA |
StemRegenin 1 |
CTRPv2 |
pan-cancer |
AAC |
0.0045 |
0.9 |
| mRNA |
salermide:PLX-4032 (12:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.0047 |
0.9 |
| mRNA |
MK-2206 |
CTRPv2 |
pan-cancer |
AAC |
0.0044 |
0.9 |
| mRNA |
ruxolitinib |
CTRPv2 |
pan-cancer |
AAC |
0.0042 |
0.9 |